Epimorphy
Epimorphy, LLC operates myDNAge®, a direct-to-consumer epigenetic biological age testing service that analyzes DNA methylation from at-home blood or urine samples using Dr. Horvath's licensed aging clock and proprietary SWARM technology, serving health-conscious adults, pet owners, and clinics.
- Company typePrivate
- Founded2016
- HeadquartersCosta Mesa, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Epimorphy does
Epimorphy, LLC operates the myDNAge® brand, a direct-to-consumer epigenetic biological age testing service founded in 2016 and headquartered in Tustin, California. The company's core product is an at-home test kit—available in blood ($299) and urine formats—that customers self-collect, mail back via prepaid return label, and receive a report by email within 4-6 weeks. The underlying technology relies on an exclusive license to Dr. Steve Horvath's 353 CpG methylation sites (the gold-standard epigenetic aging clock, cited in 600+ peer-reviewed publications), expanded to over 2,000 CpG sites and analyzed using proprietary SWARM™ (Simplified Whole-panel Amplification Reaction Method) technology with Next-Generation Sequencing. Sample processing is handled through a long-standing operational partnership with Zymo Research Corp, the company's associated research laboratory. The product is explicitly not FDA-cleared and is sold to individuals 21 or older as informational/epigenetic data rather than as a medical diagnostic.
The revenue model is one-time kit purchase (perpetual license) with no disclosed subscription or recurring billing; repeat testing is optional and positioned as longitudinal DNAge tracking. The customer base is primarily horizontal and consumer—health-conscious adults interested in longevity, with an emerging B2B clinic channel targeting anti-aging practitioners and wellness centers via a dedicated inquiry form. The portfolio was meaningfully expanded in November 2021 with Report Version 2, which added an Epi-Metabolic Index, APOE index, MTHFR index, DNAge Index peer-comparison, and DNAge History tracking, repositioning the product from a single biological-age number toward a multi-factor health report. In October 2023 the company extended its epigenetic IP into the pet category with myDogDNAge®, a canine cheek-swab biological age test. Marketing is multi-channel—content/blog, organic social, earned media (Fortune, The Guardian, BBC, Nature), email, and conferences—and the company is privately held with no institutional funding rounds disclosed in the available data.
Epimorphy firmographics
Firmographics- Name
- Epimorphy
- Legal name
- Epimorphy, LLC
- Website
- https://mydnage.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Epimorphy, LLC operates myDNAge®, a direct-to-consumer epigenetic biological age testing service that analyzes DNA methylation from at-home blood or urine samples using Dr. Horvath's licensed aging clock and proprietary SWARM technology, serving health-conscious adults, pet owners, and clinics.
- Ownership category
- akta.pro rank
Epimorphy industry classification
Industry- Product category
- Epigenetic Biological Age Testing
- NAICS
- Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511), Scientific Research and Development Services (5417)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Epigenomics & Chromatin Profiling Services (HLAGANAF)
- akta.pro secondary industries
- Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics) (HLAAAMAJ)
Keywords
Where Epimorphy is headquartered
LocationHeadquarters
- HQ city
- Costa Mesa
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Epimorphy business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Biological Age Test Kits: One-time purchase of at-home biological age test kits (blood or urine) that analyze DNA methylation patterns. Blood test priced at $299. Each kit includes sample collection materials, prepaid return envelope, and delivers results via email report within 4-6 weeks. Customers can track DNAge changes by taking multiple tests over time.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Blood Biological Age Test Kit - $299 |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels5 records
Epimorphy product offering
Product offeringCore offering
Epimorphy (operating as myDNAge) sells at-home biological age test kits that analyze DNA methylation patterns using Next-Generation Sequencing to deliver an epigenetic (biological) age reading to consumers. The company operates an exclusive license to Dr. Steve Horvath's 353 CpG site epigenetic aging clock and uses its proprietary SWARM technology to evaluate over 2,000 biomarkers. The core deliverable is a lab-generated biological age report delivered via email 4-6 weeks after sample submission.
Product overview
myDNAge is an epigenetic age determination platform offering at-home biological age testing based on Dr. Horvath's epigenetic aging clock. The core products include blood and urine collection kits that analyze DNA methylation patterns using proprietary SWARM™ technology and Next Generation Sequencing to scan over 2,000 biomarkers. The portfolio also includes myDogDNAge for canine biological age testing. The myDNAge Report Version 2 provides additional health insights through Epi-Metabolic Index, APOE, and MTHFR indexes, along with improvement plans and historical tracking for customers who take multiple tests.
Differentiator
Problem solved
Functional benefit
Brands
- myDogDNAge: A canine biological age test product using epigenetic age testing for dogs via an easy-to-use cheek swab kit.
Products and services
- myDNAge® Blood Biological Age Test At-home lancet-based blood collection kit requiring 2-3 drops of blood. Analyzes DNA methylation patterns using SWARM technology and Next-Generation Sequencing across 2,000+ CpG sites to deliver a biological age reading to adults 21+. Includes sample collection materials, prepaid return envelope, and results delivered via email in 4-6 weeks.
- myDNAge® Urine Biological Age Test At-home urine-based biological age test kit for adults 21+ who prefer a non-blood sample collection method. Provides epigenetic age analysis with results delivered via email using the same Horvath-based methylation methodology as the blood kit.
- myDogDNAge® Biological Age Test Canine biological age test kit using a simple cheek swab to determine a dog's epigenetic age from home. Targets dog owners interested in science-backed health insights for their pets and tracking canine longevity.
Quantifiable outcome
- 63% of New Year New Me Competition participants implemented lifestyle changes that resulted in a younger biological age
Companies that use Epimorphy
Customer profileSegments3 records
Ideal customer profiles3 records
Epimorphy technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature6 records
Epimorphy partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Zymo Research CorpcoreZymo Research Corp serves as Epimorphy's associated research laboratory. They work closely together to provide and improve the myDNAge service. Customer PII and samples are shared with Zymo Research for processing and analysis. The partnership enables the company's Next-Generation Sequencing capabilities and sample processing infrastructure.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Epimorphy competitors and assessment
Company assessmentEmerging players
- ZOE: Personalized nutrition and metabolic health company offering at-home blood fat and glucose response testing with a membership model. Comparable to Epimorphy as a premium at-home consumer health testing brand in the longevity-adjacent category, with a subscription-style business model.
- Viome: Personalized health company offering at-home gut microbiome and transcriptomic testing with food/supplement recommendations. Comparable to Epimorphy in the DTC at-home molecular testing model and longevity-adjacent positioning, with partial overlap in the "biological age" narrative.
Direct peers
- Elysium Health: Longevity-focused company offering the Elysium Index biological age test alongside its supplement line. Directly comparable to Epimorphy in combining epigenetic age testing with consumer longevity products, targeting the same health-conscious adult segment.
- InsideTracker: Personalized health and longevity testing platform offering blood-based biological age (InnerAge) and wellness biomarker panels. Comparable in combining biological age testing with a broader wellness optimization pitch, at a similar consumer price point.
- GlycanAge: Direct-to-consumer biological age test using glycan biomarkers (N-glycome) rather than DNA methylation. Highly comparable to Epimorphy in business model (DTC biological age test kit, consumer wellness positioning) while being an adjacent biomarker approach in the same category.
- TallyHealth: Direct-to-consumer biological age testing brand offering at-home epigenetic age tests and longevity supplements. Closest direct competitor to myDNAge, operating a similar DTC e-commerce model with an at-home epigenetic test kit for health-conscious adults.
- TruDiagnostic: Epigenetic testing company offering biological age and multi-omic tests using next-generation clocks including GrimAge, PhenoAge, and DunedinPACE. Comparable to Epimorphy as a lab-based epigenetic age test provider, with a more clinically-oriented go-to-market and newer clock offerings.
Broad incumbents
- Thorne: Well-established supplements and health testing brand offering at-home tests (including biological age) alongside a large supplement portfolio. Comparable to Epimorphy in the consumer longevity segment, but with much broader scope and distribution including practitioner and pro-athlete channels.
- 23andMe: Established consumer genetic testing brand offering at-home DNA test kits including health, ancestry, and trait reports. Comparable to Epimorphy in the DTC at-home DNA testing model, but operates as a broad incumbent across many genetic testing categories rather than specializing in epigenetic biological age.
- Everlywell: Large-scale DTC at-home health testing platform (now part of Everly Health) offering dozens of test kits across categories. Comparable to Epimorphy in the at-home collection, mail-in, e-commerce distribution model, but as a broad incumbent across many test categories rather than specializing in biological age.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Epimorphy social profiles
Digital presenceEpimorphy compliance and trust
Trust signalCompliance1 record
Epimorphy financial estimates
Financial estimateRevenue estimate
Valuation estimate
Epimorphy leadership team
Management profileNumber of profiles
Epimorphy funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Epimorphy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Epimorphy
What does Epimorphy do?
Epimorphy (operating as myDNAge) sells at-home biological age test kits that analyze DNA methylation patterns using Next-Generation Sequencing to deliver an epigenetic (biological) age reading to consumers. The company operates an exclusive license to Dr. Steve Horvath's 353 CpG site epigenetic aging clock and uses its proprietary SWARM technology to evaluate over 2,000 biomarkers. The core deliverable is a lab-generated biological age report delivered via email 4-6 weeks after sample submission.
Is Epimorphy a public or private company?
Epimorphy is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Epimorphy founded?
Epimorphy was founded in 2016. It employs 1 to 10 people.
Where is Epimorphy based?
Epimorphy is headquartered in Costa Mesa, United States, in the North America region.
How does Epimorphy make money?
One revenue line is on record: biological Age Test Kits.
Who are Epimorphy's main competitors?
Emerging players on record are ZOE and Viome. Direct peers are Elysium Health, InsideTracker, GlycanAge, TallyHealth and TruDiagnostic. Broad incumbents are Thorne, 23andMe and Everlywell.
Does Epimorphy have an API?
No public API is recorded for Epimorphy.
What industry is Epimorphy in?
Epimorphy's product category is Epigenetic Biological Age Testing. Its primary akta.pro industry code is HLAGANAF, Epigenomics & Chromatin Profiling Services, with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 6215 and its SIC code is 8071.